Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2598729rdf:typepubmed:Citationlld:pubmed
pubmed-article:2598729lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2598729lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:2598729lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:2598729lifeskim:mentionsumls-concept:C0007465lld:lifeskim
pubmed-article:2598729lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:2598729pubmed:issue8lld:pubmed
pubmed-article:2598729pubmed:dateCreated1990-2-8lld:pubmed
pubmed-article:2598729pubmed:abstractTextThe long-term prognosis and causes of death of myocardial infarction (MI) in 62 patients with diabetes were studied. The mean follow-up time was 6.2 years. 11 cases died in the acute period of MI (8 weeks following onset of AMI), 9 cases of them (81.8%) had anterior infarction and their major causes of death were ventricular fibrillation and cardiogenic shock (72.2%). 19 cases died in the follow-up period, among them 14 cases (73.68%) had inferior and anterior-septal infarction; most of them died of reinfarction and sudden death. The cumulative survival rate 1.2 and 5 years after MI was 80.7%, 71.9% and 57.9%, respectively. The blood glucose level of the fatal group and the level of CPK and GOT of patients who died in the acute period were higher than those in the surviving group. The results suggest that treatment of myocardial infarction in patients with diabetes be more attentive to prevent ventricular fibrillation and cardiogenic shock during the acute period. After the acute period more attention should be paid to prevent reinfarction and and drop the blood glucose level at normal as possible.lld:pubmed
pubmed-article:2598729pubmed:languagechilld:pubmed
pubmed-article:2598729pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2598729pubmed:citationSubsetIMlld:pubmed
pubmed-article:2598729pubmed:statusMEDLINElld:pubmed
pubmed-article:2598729pubmed:monthAuglld:pubmed
pubmed-article:2598729pubmed:issn0578-1426lld:pubmed
pubmed-article:2598729pubmed:authorpubmed-author:YuhYYlld:pubmed
pubmed-article:2598729pubmed:authorpubmed-author:QianR LRLlld:pubmed
pubmed-article:2598729pubmed:authorpubmed-author:FengJ GJGlld:pubmed
pubmed-article:2598729pubmed:issnTypePrintlld:pubmed
pubmed-article:2598729pubmed:volume28lld:pubmed
pubmed-article:2598729pubmed:ownerNLMlld:pubmed
pubmed-article:2598729pubmed:authorsCompleteYlld:pubmed
pubmed-article:2598729pubmed:pagination469-72, 509lld:pubmed
pubmed-article:2598729pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:meshHeadingpubmed-meshheading:2598729-...lld:pubmed
pubmed-article:2598729pubmed:year1989lld:pubmed
pubmed-article:2598729pubmed:articleTitle[Causes of death and prognosis of myocardial infarction in patients with diabetes].lld:pubmed
pubmed-article:2598729pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2598729pubmed:publicationTypeEnglish Abstractlld:pubmed